Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets

Autores
Brevedan, Marta Ingrid Victoria; Varillas, María Alejandra; González Vidal, Noelia Luján
Año de publicación
2022
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Similarity studies are used with the intention to establish interchangeability of certain formulations in vitro, without the need to carry out in vivo studies. This interchangeability between formulations should be conserved during the product shelf life, as an integral part of the pharmaceutical stability. Hydrochlorothiazide (HCTZ), a widely used diuretic, is classified as a class 3 drug in the Biopharmaceutics Classification System (BCS). An immediate-release (IR) solid oral formulation containing a class 3 drug is a candidate for biowaiver if it meets the requirement of ῾very rapid dissolution’ (i.e., ≥ 85% dissolved within 15 minutes). This research aimed to compare four solid oral IR HCTZ formulations (50 mg), commercially available in Argentina, with respect to pharmaceutical similarity and stability. To assess for similarity, dissolution profiles were compared both at time zero (T0) and after 12 months of storage (T12) at pH 1.2, 4.5, and 6.8. To assess for stability, critical quality attributes (CQAs) of the samples were evaluated at T12 of storage (25 °C, 60% relative humidity). At T12, all samples met the requirements for CQAs (i.e., assay, friability, disintegration, uniformity, and dissolution). The reference formulation had the fastest dissolution rate, and sample D was the slowest. Two multisource formulations exhibited statistical differences with respect to the reference sample, both at T0 and T12. Because the evaluated multisource formulations did not meet criteria for very rapid dissolution, they are not candidates for biowaivers. In terms of stability, some statistical differences were detected between dissolution performance at T0 and T12 (for some samples and dissolution media), but no specific pattern could be detected. Thus, it can be considered that the storage conditions did not affect the critical quality attributes of evaluated samples, and their pharmaceutical equivalence was maintained.
Fil: Brevedan, Marta Ingrid Victoria. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina
Fil: Varillas, María Alejandra. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina
Fil: González Vidal, Noelia Luján. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca; Argentina. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina
Materia
BIOWAIVER
CRITICAL QUALITY ATTRIBUTES
DISSOLUTION
HYDROCHLOROTHIAZIDE (HCTZ)
STABILITY
STORAGE
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/217803

id CONICETDig_dae01cb3fb461ce3415f7f45ecdeba57
oai_identifier_str oai:ri.conicet.gov.ar:11336/217803
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tabletsBrevedan, Marta Ingrid VictoriaVarillas, María AlejandraGonzález Vidal, Noelia LujánBIOWAIVERCRITICAL QUALITY ATTRIBUTESDISSOLUTIONHYDROCHLOROTHIAZIDE (HCTZ)STABILITYSTORAGEhttps://purl.org/becyt/ford/2.11https://purl.org/becyt/ford/2https://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3https://purl.org/becyt/ford/1.4https://purl.org/becyt/ford/1Similarity studies are used with the intention to establish interchangeability of certain formulations in vitro, without the need to carry out in vivo studies. This interchangeability between formulations should be conserved during the product shelf life, as an integral part of the pharmaceutical stability. Hydrochlorothiazide (HCTZ), a widely used diuretic, is classified as a class 3 drug in the Biopharmaceutics Classification System (BCS). An immediate-release (IR) solid oral formulation containing a class 3 drug is a candidate for biowaiver if it meets the requirement of ῾very rapid dissolution’ (i.e., ≥ 85% dissolved within 15 minutes). This research aimed to compare four solid oral IR HCTZ formulations (50 mg), commercially available in Argentina, with respect to pharmaceutical similarity and stability. To assess for similarity, dissolution profiles were compared both at time zero (T0) and after 12 months of storage (T12) at pH 1.2, 4.5, and 6.8. To assess for stability, critical quality attributes (CQAs) of the samples were evaluated at T12 of storage (25 °C, 60% relative humidity). At T12, all samples met the requirements for CQAs (i.e., assay, friability, disintegration, uniformity, and dissolution). The reference formulation had the fastest dissolution rate, and sample D was the slowest. Two multisource formulations exhibited statistical differences with respect to the reference sample, both at T0 and T12. Because the evaluated multisource formulations did not meet criteria for very rapid dissolution, they are not candidates for biowaivers. In terms of stability, some statistical differences were detected between dissolution performance at T0 and T12 (for some samples and dissolution media), but no specific pattern could be detected. Thus, it can be considered that the storage conditions did not affect the critical quality attributes of evaluated samples, and their pharmaceutical equivalence was maintained.Fil: Brevedan, Marta Ingrid Victoria. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; ArgentinaFil: Varillas, María Alejandra. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; ArgentinaFil: González Vidal, Noelia Luján. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca; Argentina. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; ArgentinaDissolution Technologies, Inc2022-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/217803Brevedan, Marta Ingrid Victoria; Varillas, María Alejandra; González Vidal, Noelia Luján; Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets; Dissolution Technologies, Inc; Dissolution Technologies; 29; 4; 11-2022; 1-91521-298XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://dissolutiontech.com/issues/202211/HCTZ.pdfinfo:eu-repo/semantics/altIdentifier/doi/10.14227/DT290422PGC1info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:11:29Zoai:ri.conicet.gov.ar:11336/217803instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:11:29.793CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets
title Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets
spellingShingle Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets
Brevedan, Marta Ingrid Victoria
BIOWAIVER
CRITICAL QUALITY ATTRIBUTES
DISSOLUTION
HYDROCHLOROTHIAZIDE (HCTZ)
STABILITY
STORAGE
title_short Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets
title_full Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets
title_fullStr Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets
title_full_unstemmed Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets
title_sort Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets
dc.creator.none.fl_str_mv Brevedan, Marta Ingrid Victoria
Varillas, María Alejandra
González Vidal, Noelia Luján
author Brevedan, Marta Ingrid Victoria
author_facet Brevedan, Marta Ingrid Victoria
Varillas, María Alejandra
González Vidal, Noelia Luján
author_role author
author2 Varillas, María Alejandra
González Vidal, Noelia Luján
author2_role author
author
dc.subject.none.fl_str_mv BIOWAIVER
CRITICAL QUALITY ATTRIBUTES
DISSOLUTION
HYDROCHLOROTHIAZIDE (HCTZ)
STABILITY
STORAGE
topic BIOWAIVER
CRITICAL QUALITY ATTRIBUTES
DISSOLUTION
HYDROCHLOROTHIAZIDE (HCTZ)
STABILITY
STORAGE
purl_subject.fl_str_mv https://purl.org/becyt/ford/2.11
https://purl.org/becyt/ford/2
https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
https://purl.org/becyt/ford/1.4
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Similarity studies are used with the intention to establish interchangeability of certain formulations in vitro, without the need to carry out in vivo studies. This interchangeability between formulations should be conserved during the product shelf life, as an integral part of the pharmaceutical stability. Hydrochlorothiazide (HCTZ), a widely used diuretic, is classified as a class 3 drug in the Biopharmaceutics Classification System (BCS). An immediate-release (IR) solid oral formulation containing a class 3 drug is a candidate for biowaiver if it meets the requirement of ῾very rapid dissolution’ (i.e., ≥ 85% dissolved within 15 minutes). This research aimed to compare four solid oral IR HCTZ formulations (50 mg), commercially available in Argentina, with respect to pharmaceutical similarity and stability. To assess for similarity, dissolution profiles were compared both at time zero (T0) and after 12 months of storage (T12) at pH 1.2, 4.5, and 6.8. To assess for stability, critical quality attributes (CQAs) of the samples were evaluated at T12 of storage (25 °C, 60% relative humidity). At T12, all samples met the requirements for CQAs (i.e., assay, friability, disintegration, uniformity, and dissolution). The reference formulation had the fastest dissolution rate, and sample D was the slowest. Two multisource formulations exhibited statistical differences with respect to the reference sample, both at T0 and T12. Because the evaluated multisource formulations did not meet criteria for very rapid dissolution, they are not candidates for biowaivers. In terms of stability, some statistical differences were detected between dissolution performance at T0 and T12 (for some samples and dissolution media), but no specific pattern could be detected. Thus, it can be considered that the storage conditions did not affect the critical quality attributes of evaluated samples, and their pharmaceutical equivalence was maintained.
Fil: Brevedan, Marta Ingrid Victoria. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina
Fil: Varillas, María Alejandra. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina
Fil: González Vidal, Noelia Luján. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca; Argentina. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina
description Similarity studies are used with the intention to establish interchangeability of certain formulations in vitro, without the need to carry out in vivo studies. This interchangeability between formulations should be conserved during the product shelf life, as an integral part of the pharmaceutical stability. Hydrochlorothiazide (HCTZ), a widely used diuretic, is classified as a class 3 drug in the Biopharmaceutics Classification System (BCS). An immediate-release (IR) solid oral formulation containing a class 3 drug is a candidate for biowaiver if it meets the requirement of ῾very rapid dissolution’ (i.e., ≥ 85% dissolved within 15 minutes). This research aimed to compare four solid oral IR HCTZ formulations (50 mg), commercially available in Argentina, with respect to pharmaceutical similarity and stability. To assess for similarity, dissolution profiles were compared both at time zero (T0) and after 12 months of storage (T12) at pH 1.2, 4.5, and 6.8. To assess for stability, critical quality attributes (CQAs) of the samples were evaluated at T12 of storage (25 °C, 60% relative humidity). At T12, all samples met the requirements for CQAs (i.e., assay, friability, disintegration, uniformity, and dissolution). The reference formulation had the fastest dissolution rate, and sample D was the slowest. Two multisource formulations exhibited statistical differences with respect to the reference sample, both at T0 and T12. Because the evaluated multisource formulations did not meet criteria for very rapid dissolution, they are not candidates for biowaivers. In terms of stability, some statistical differences were detected between dissolution performance at T0 and T12 (for some samples and dissolution media), but no specific pattern could be detected. Thus, it can be considered that the storage conditions did not affect the critical quality attributes of evaluated samples, and their pharmaceutical equivalence was maintained.
publishDate 2022
dc.date.none.fl_str_mv 2022-11
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/217803
Brevedan, Marta Ingrid Victoria; Varillas, María Alejandra; González Vidal, Noelia Luján; Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets; Dissolution Technologies, Inc; Dissolution Technologies; 29; 4; 11-2022; 1-9
1521-298X
CONICET Digital
CONICET
url http://hdl.handle.net/11336/217803
identifier_str_mv Brevedan, Marta Ingrid Victoria; Varillas, María Alejandra; González Vidal, Noelia Luján; Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets; Dissolution Technologies, Inc; Dissolution Technologies; 29; 4; 11-2022; 1-9
1521-298X
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://dissolutiontech.com/issues/202211/HCTZ.pdf
info:eu-repo/semantics/altIdentifier/doi/10.14227/DT290422PGC1
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Dissolution Technologies, Inc
publisher.none.fl_str_mv Dissolution Technologies, Inc
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842270160271966208
score 13.13397